Nyxoah S.A. announced the appointment of Christoph Eigenmann as Chief Commercial Officer. Christoph will oversee commercial activities globally, be responsible for sales and marketing in existing markets, and new market development. Christoph brings a wealth of experience in medical technologies to Nyxoah.

He spent over 20 years with Johnson & Johnson (J&J), where he oversaw commercial organizations in various geographies in Europe and the United States. He has extensive experience in managing orthopedic and neuro businesses in the German, Swiss and U.S. markets, including as Senior Vice President, Sales & Marketing for J&J's close to $1 billion Spine franchise, and has led regional functions across EMEA and North America. Christoph holds a master's degree in chemical engineering and biotechnology from the Swiss Federal Institute of Technology in Lausanne, Switzerland.